You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
CD133 expression in colorectal adenomas
  1. Adriana Handra-Luca1,2,
  2. Sarah Taconet2
  1. 1 Service d'Anatomie pathologique, APHP GHU Avicenne, Bobigny, France
  2. 2 Universite Paris Nord Sorbonne Cite, Bobigny, France
  1. Correspondence to Dr Adriana Handra-Luca, Service d'Anatomie Pathologique, APHP GHU Avicenne, Universite Paris Nord Sorbonne Cite, 125 rue de Stalingrad, Bobigny 93000, France; adriana.handra-luca{at}avc.aphp.fr

https://doi.org/10.1136/jclinpath-2013-201843

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We have read with great interest the recent publication on the stem cell marker CD133 and serrated and hyperplastic intestinal polyps by Mohammadi et al. 1 Although adenomas are the most frequent type of benign colorectal polyp, there are limited published data on CD133 expression.2 ,3 We examined the patterns of CD133 expression by immunohistochemistry in 110 colorectal adenoma tissue specimens on tissue microarrays (CD133 clone C24B9, 1:50 dilution; Cell Signaling Technology; Ventana Benchmark ISH/IHC). All hematoxilin and eosin (H&E) stained slides were reviewed and representative low- and high-grade dysplasia zones were selected. Tissue cores (two) of 0.6 mm from these zones were used to construct the tissue microarray block (Tissu Arrayer MiniCore 3, Excilone). Main morphological characteristics of adenoma (size, degree of dysplasia, tubular or villous architecture, extent of epithelial mucosecretion) were assessed on the H&E stained whole section slides. The relationships between CD133 expression and these characteristics were analysed by Fisher's test and logistic regression models …

    View Full Text

    Footnotes

    • Contributors AHL: data and results analysis, manuscript writing, ST: manuscript writing.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.